Drug Database
Back to search

Netherlands· NL-eefe0825814c

Ledermycin, capsules 300 mg

A demeclocycline product containing demeclocycline hydrochloride, registered in Netherlands by Eurocept International B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC J01AA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLedermycin, capsules 300 mgATCJ01AA01REGISTER NO.NL-eefe0825814cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about demeclocycline hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Demeclocycline is registered in 5 of 19 countries.

Countries holding a registration under ATC J01AA01 (demeclocycline), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search demeclocycline products by name

Demeclocycline · ATC J01AA01

5 / 19 countries

  • Finlandprice
  • Japan
  • Netherlands
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DEMECLOCYCLINE HYDROCHLORIDE
Manufacturer
Eurocept International B.V.
Country
Netherlands (NL)
ATC code
J01AA01
ATC class
Demeclocycline
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    05047

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

169 interactions on record for demeclocycline.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check demeclocycline against other medicinesHow interaction checks work

Demeclocycline · interactions on record

169 records

  • 10 severe
  • 132 moderate
  • 27 minor

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Demeclocycline in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All demeclocycline products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Demeclocycline Acetlab
  • United Kingdom (Northern Ireland) · Demeclocycline Hydrochloride Dawa, Demeclocycline Hydrochloride Mercury Pharmaceuticals

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ffeb0dba-f4f4-4c8f-b1d0-e66170438745
GET /v1/drugs/ffeb0dba-f4f4-4c8f-b1d0-e66170438745?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05047_smpc.pdf",
  "strength": null,
  "atc_label": "Demeclocycline",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05047",
  "excipients": [
    "ERYTHROSINE (E 127)",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN (E 132)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "DEMECLOCYCLINE HYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05047.pdf",
  "authorised_at": "1966/03/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05047",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about demeclocycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console